Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust. More than 250,000 women around the world are diagnosed with ovarian cancer every year, with almost half dying from the disease. This makes ovarian cancer the most common cause of death from a gynaecological malignancy. Late diagnosis a key contributing factor. © Dr Siobhan Ferguson & Ian Hindle (Dianne Oxberry Trust), Prof Ahmed Ahmed, Abdulkhaliq Alsaadi & Mara Artibani (Weatherall Institute of Molecular Medicine, NDWRH, Oxford University)

Research into the early detection of ovarian cancer will receive a boost, thanks to a gift of £43,000 from the Dianne Oxberry Trust. The donation will support doctoral candidate Abdulkhaliq Alsaadi in this research by covering the stipend and other costs associated with his final year of study, including research consumables.

More than 250,000 women around the world are diagnosed with ovarian cancer every year, with almost half dying from the disease. This makes ovarian cancer the most common cause of death from a gynaecological malignancy. Late diagnosis a key contributing factor.

At Oxford, a concerted effort is being made to better understand the origins of the disease. Led by Professor Ahmed Ahmed, Professor of Gynaecological Oncology in the Nuffield Department of Women’s and Reproductive Health, researchers are utilising cutting-edge methodologies to classify the cells in the fallopian tube – thought to be the organ from which most ovarian cancers develop. It is hoped that this will lead to the discovery of new biomarkers that could be used for pre-cancer screening.

Working under Professor Ahmed’s supervision, Abdulkhaliq is developing a system for growing fallopian tub­e organoids (mini-fallopian tubes) in the lab. These organoids can be used to investigate the different cell types within fallopian tubes, and model how ovarian cancer starts. The Dianne Oxberry Trust’s generosity will enable Abdulkhaliq to continue this important work for a further year. 

Professor Ahmed says: ‘This very generous donation from the Dianne Oxberry Trust will support our endeavours to better understand how ovarian cancer begins. Early detection is crucial to surviving this terrible disease, and this funding from the Dianne Oxberry Trust gets us one step closer to reaching that goal.’

The Dianne Oxberry Trust was set up in the memory of BBC presenter Dianne Oxberry, who died from ovarian cancer in January 2019, at the age of 51. Established by her husband Ian Hindle, the trust supports those affected by ovarian cancer through the provision of grants, information and advice.

‘The work Professor Ahmed and his team are doing is incredible,’ says Ian. ‘Hopefully with our donation we are going to make a difference.’

Dr Siobhan Ferguson, Trustee of the Dianne Oxberry Trust, adds: ‘Knowing what we know about what happened to Dianne, how short her journey was, the emphasis on early diagnosis is so important. You really get a sense that the team are breaking ground and that they will perhaps, within our lifetime, be able to spot women much earlier in the disease process.’

 

 

Latest news

MitOX 2020 Bookings open

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2020 on Friday 3rd April 2020 in Oxford. It's our annual meeting packed with short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.

How do unborn babies and mothers communicate via the placenta?

DPhil student Neva Kandzija wins an Oxford Sparks competition to have her Placenta research transformed into a two minute animation film for free.

100 000 babies screened for increased type 1 diabetes risk in the INGR1D Study

Celebrating a major milestone for one of Europe’s biggest type 1 diabetes research cooperations: The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has successfully screened 100,000 newborns across Europe (including over 7500 newborns in the Thames Valley) for an increased genetic risk of developing type 1 diabetes.

2019 Max Perutz Science Writing Award shortlist announced

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition. The shortlist includes our DPhil student Magda Mareckova (pictured).